Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
7.20
-0.08 (-1.08%)
At close: Aug 22, 2025, 4:00 PM
7.20
0.00 (-0.02%)
After-hours: Aug 22, 2025, 5:58 PM EDT
Quoin Pharmaceuticals Employees
As of December 31, 2024, Quoin Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$2,433,855
Market Cap
4.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | 1 | 25.00% |
| Dec 31, 2023 | 4 | 0 | - |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | 2 | 100.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QNRX News
- 6 days ago - Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy - GlobeNewsWire
- 12 days ago - Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton - GlobeNewsWire
- 26 days ago - Quoin Pharmaceuticals Provides Product Portfolio Update - GlobeNewsWire
- 3 months ago - Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome - GlobeNewsWire
- 3 months ago - Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study - GlobeNewsWire
- 4 months ago - Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - GlobeNewsWire
- 4 months ago - Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign - GlobeNewsWire
- 5 months ago - Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient - GlobeNewsWire